You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Contrave

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Utilisation of Mysimba/Contrave

Completed
  • Obesity
    • Nashville, Tennessee
      Currax Pharmaceuticals
    Oct 17, 2023

    Real-World Evidence on Cardiovascular Safety of CONTRAVE® in

    Completed
    • Obesity
      • Brentwood, Tennessee
        Currax Pharmaceuticals
      Oct 17, 2023

      Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

      Not yet recruiting
      • Obesity
      • Naltrexone-Bupropion (NB) Combination
      • Placebo
      • (no location specified)
      Oct 18, 2023

      Obesity Trial in Scottsbluff (Intervention Control, Counselling, Contrave)

      Completed
      • Obesity
      • Intervention Control
      • +3 more
      • Scottsbluff, Nebraska
      • +1 more
      Nov 5, 2022

      Obesity Trial in New York (Naltrexone-Bupropion Combination)

      Recruiting
      • Obesity
      • Naltrexone-Bupropion Combination
      • New York, New York
        Columbia University Medical Center
      Jun 16, 2023

      Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)

      Not yet recruiting
      • Stimulant Use
      • +3 more
      • Contrave 8Mg-90Mg Extended-Release Tablet
      • Bupropion
      • Los Angeles, California
        University of California Los Angeles
      Aug 31, 2022

      Obesity, Morbid, Bariatric Surgery Candidate, Medication Persistence Trial (Naltrexone-Bupropion Combination)

      Not yet recruiting
      • Obesity, Morbid
      • +2 more
      • Naltrexone-Bupropion Combination
      • (no location specified)
      Jul 26, 2022

      Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)

      Recruiting
      • Obesity
      • Loma Linda, California
        Novo Nordisk Investigational Site
      Jan 24, 2023

      Loss-of-control Eating, Obesity/Overweight Trial in New Haven (drug, behavioral, other)

      Recruiting
      • Loss-of-control Eating
      • Obesity/Overweight
      • Naltrexone and Bupropion medication
      • +2 more
      • New Haven, Connecticut
        Yale Department of Psychiatry
      Oct 4, 2022

      Loss-of-Control Eating, Obesity/Overweight Trial in New Haven (Naltrexone and Bupropion (NB) medication, Placebo)

      Enrolling by invitation
      • Loss-of-Control Eating
      • Obesity/Overweight
      • Naltrexone and Bupropion (NB) medication
      • Placebo
      • New Haven, Connecticut
        Yale School of Medicine
      Oct 4, 2022

      Breast Cancer, Overweight or Obesity Trial in Baltimore (Contrave, Behavioral Weight Loss)

      Recruiting
      • Breast Cancer
      • Overweight or Obesity
      • Contrave
      • Behavioral Weight Loss
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Nov 2, 2022

      Binge-Eating Disorder, Obesity Trial in New Haven (Cognitive-Behavioral Therapy (CBT), NB Medication (on-going from acute

      Active, not recruiting
      • Binge-Eating Disorder
      • Obesity
      • Cognitive-Behavioral Therapy (CBT)
      • NB Medication (on-going from acute treatment)
      • New Haven, Connecticut
        Yale School of Medicine
      Jul 27, 2022

      Binge-Eating Disorder Trial in New Haven (Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination, Placebo)

      Active, not recruiting
      • Binge-Eating Disorder
      • Bupropion Hydrochloride, Naltrexone Hydrochoride Drug Combination
      • Placebo
      • New Haven, Connecticut
        Yale School of Medicine
      Feb 18, 2022

      Obesity Trial in Canada (Contrave 8Mg-90Mg Extended-Release Tablet, Placebo)

      Not yet recruiting
      • Obesity
      • Contrave 8Mg-90Mg Extended-Release Tablet
      • Placebo
      • Guelph, Ontario, Canada
      • +3 more
      Oct 13, 2020

      Obesity Trial in Canada (Contrave 8Mg-90Mg Extended-Release Tablet, Placebo)

      Unknown status
      • Obesity
      • Contrave 8Mg-90Mg Extended-Release Tablet
      • Placebo
      • Guelph, Ontario, Canada
      • +3 more
      Oct 9, 2020

      Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)

      Active, not recruiting
      • Bipolar Disorder
      • Obesity
      • Mason, Ohio
        Lindner Center of HOPE
      May 24, 2022

      Obesity Trial in Cleveland (Phentermine 37.5 Mg, Dietary program, Exercise program)

      Completed
      Has Results
      • Obesity
      • Phentermine 37.5 Mg
      • +2 more
      • Cleveland, Ohio
        Cleveland Clinic
      Nov 14, 2022

      Obesity Trial in Cleveland (Weight Management Program (WMP), Medication for chronic weight management (Rx))

      Completed
      Has Results
      • Obesity
      • Weight Management Program (WMP)
      • Medication for chronic weight management (Rx)
      • Cleveland, Ohio
        Novo Nordisk Investigational Site
      Nov 10, 2022

      Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)

      Terminated
      Has Results
      • Obesity
      • Cardiovascular Diseases
      • Naltrexone HCl/Bupropion HCl ER
      • Placebo
      • Alexander City, Alabama
      • +138 more
      Feb 21, 2017

      Obesity, Overweight Trial in United States (NB32, PBO, Weight Management Program)

      Terminated
      Has Results
      • Obesity
      • Overweight
      • Birmingham, Alabama
      • +223 more
      Feb 24, 2017

      Healthy Trial in Overland Park (Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets), Test

      Completed
      • Healthy
      • Reference naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets)
      • Test naltrexone 8 mg SR/bupropion 90 mg SR combination trilayer tablets (2 tablets)
      • Overland Park, Kansas
        Quintiles Phase One Services, LLC
      Dec 10, 2014

      Nicotine Dependence, Overweight, Obesity Trial in Encino, Los Alamitos, Newport Beach (NB32, Ancillary therapy)

      Completed
      • Nicotine Dependence
      • +2 more
      • Encino, California
      • +2 more
      Oct 31, 2012